• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: dbr:Bortezomib     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatAmidesyago:WikicatBoronCompoundsyago:WikicatBoronicAcidsyago:WikicatMolecularFormulasyago:WikicatOrganoboronCompoundsyago:Abstraction100002137yago:Acid114607521yago:Amide114724264yago:Chemical114806838yago:Cognition100023271yago:Communication100033020yago:Compound105870180yago:Compound114818238yago:Concept105835747yago:Content105809192yago:Formula106816935yago:Idea105833840yago:LanguageUnit106284225yago:Material114580897yago:Matter100020827yago:Message106598915yago:MolecularFormula106817173yago:Name106333653yago:OrganicCompound114727670yago:Part113809207yago:PhysicalEntity100001930yago:PsychologicalFeature100023100yago:Relation100031921yago:WikicatJohnson&JohnsonBrandsdrugyago:Statement106722453yago:Substance100019613yago:TradeName106845599yago:Whole105869584umbel-rc:DrugProduct New Facet based on Instances of this Class

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection. Bortezomib was approved for medical use in the United States in 2003 and in the European Union in 2004. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.